180 related articles for article (PubMed ID: 15050638)
1. Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives.
Marastoni M; McDonald J; Baldisserotto A; Canella A; De Risi C; Pollini GP; Tomatis R
Bioorg Med Chem Lett; 2004 Apr; 14(8):1965-8. PubMed ID: 15050638
[TBL] [Abstract][Full Text] [Related]
2. Arecoline tripeptide inhibitors of proteasome.
Marastoni M; Baldisserotto A; Canella A; Gavioli R; Risi CD; Pollini GP; Tomatis R
J Med Chem; 2004 Mar; 47(6):1587-90. PubMed ID: 14998343
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors.
Zhu Y; Yao S; Xu B; Ge Z; Cui J; Cheng T; Li R
Bioorg Med Chem; 2009 Oct; 17(19):6851-61. PubMed ID: 19747832
[TBL] [Abstract][Full Text] [Related]
4. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
[TBL] [Abstract][Full Text] [Related]
5. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
[TBL] [Abstract][Full Text] [Related]
6. Structure-based optimisation of 2-aminobenzylstatine derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Furet P; Imbach P; Fuerst P; Lang M; Noorani M; Zimmermann J; García-Echeverría C
Bioorg Med Chem Lett; 2002 May; 12(10):1331-4. PubMed ID: 11992770
[TBL] [Abstract][Full Text] [Related]
7. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
[TBL] [Abstract][Full Text] [Related]
8. New polyhydroxy sterols: proteasome inhibitors from a marine sponge Acanthodendrilla sp.
Tsukamoto S; Tatsuno M; van Soest RW; Yokosawa H; Ohta T
J Nat Prod; 2003 Sep; 66(9):1181-5. PubMed ID: 14510593
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of new vinyl ester pseudotripeptide proteasome inhibitors.
Marastoni M; Baldisserotto A; Trapella C; Gavioli R; Tomatis R
Eur J Med Chem; 2006 Aug; 41(8):978-84. PubMed ID: 16713026
[TBL] [Abstract][Full Text] [Related]
10. A new structural class of selective and non-covalent inhibitors of the chymotrypsin-like activity of the 20S proteasome.
García-Echeverría C; Imbach P; France D; Fürst P; Lang M; Noorani AM; Scholz D; Zimmermann J; Furet P
Bioorg Med Chem Lett; 2001 May; 11(10):1317-9. PubMed ID: 11392545
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides.
Baldisserotto A; Franceschini C; Scalambra F; Trapella C; Marastoni M; Sforza F; Gavioli R; Tomatis R
J Pept Sci; 2010 Nov; 16(11):659-63. PubMed ID: 20814885
[TBL] [Abstract][Full Text] [Related]
12. Vinyl ester-based cyclic peptide proteasome inhibitors.
Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
[TBL] [Abstract][Full Text] [Related]
13. A short, stereocontrolled, and practical synthesis of alpha-methylomuralide, a potent inhibitor of proteasome function.
Saravanan P; Corey EJ
J Org Chem; 2003 Apr; 68(7):2760-4. PubMed ID: 12662049
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors.
Watanabe T; Momose I; Abe M; Abe H; Sawa R; Umezawa Y; Ikeda D; Takahashi Y; Akamatsu Y
Bioorg Med Chem Lett; 2009 Apr; 19(8):2343-5. PubMed ID: 19307118
[TBL] [Abstract][Full Text] [Related]
15. Effects of protease inhibitors on binding of sperm to the vitelline coat of ascidian eggs: implications for participation of a proteasome (multicatalytic proteinase complex).
Takizawa S; Sawada H; Someno T; Saitoh Y; Yokosawa H; Hoshi M
J Exp Zool; 1993 Sep; 267(1):86-91. PubMed ID: 8376953
[TBL] [Abstract][Full Text] [Related]
16. TMC-95-based inhibitor design provides evidence for the catalytic versatility of the proteasome.
Groll M; Götz M; Kaiser M; Weyher E; Moroder L
Chem Biol; 2006 Jun; 13(6):607-14. PubMed ID: 16793518
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome.
Momose I; Umezawa Y; Hirosawa S; Iijima M; Iinuma H; Ikeda D
Biosci Biotechnol Biochem; 2005 Sep; 69(9):1733-42. PubMed ID: 16195592
[TBL] [Abstract][Full Text] [Related]
18. Modeling of the binding mode of a non-covalent inhibitor of the 20S proteasome. Application to structure-based analogue design.
Furet P; Imbach P; Fürst P; Lang M; Noorani M; Zimmermann J; García-Echeverria C
Bioorg Med Chem Lett; 2001 May; 11(10):1321-4. PubMed ID: 11392546
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of new 3-alkoxy-7-amino-4-chloro-isocoumarin derivatives as new beta-amyloid peptide production inhibitors and their activities on various classes of protease.
Bihel F; Quéléver G; Lelouard H; Petit A; Alvès da Costa C; Pourquié O; Checler F; Thellend A; Pierre P; Kraus JL
Bioorg Med Chem; 2003 Jul; 11(14):3141-52. PubMed ID: 12818677
[TBL] [Abstract][Full Text] [Related]
20. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors.
Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L
J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
